The Strides Arcolab board of directors at a meeting held on September 29, 2014, approved a scheme of amalgamation between the company and Shasun Pharmaceuticals wherein, Shasun Pharmaceuticals will amalgamate with the Company. The scheme of amalgamation is subject to various statutory and regulatory approvals, as may be applicable. Shareholders will get five shares of Strides for every 16 shares held in Shasun. The merger will be an all-stock transaction. The Strides Arcolab board will also consider special dividend on October 7.
Strides Arcolab stock price On September 29, 2014, at 15:12 hrs Strides Arcolab was quoting at Rs 716.10, up Rs 73.30, or 11.40 percent. The 52-week high of the share was Rs 1050.00 and the 52-week low was Rs 343.80. The company's trailing 12-month (TTM) EPS was at Rs 588.59 per share as per the quarter ended June 2014. The stock's price-to-earnings (P/E) ratio was 1.22. The latest book value of the company is Rs 273.80 per share. At current value, the price-to-book value of the company is 2.62.
No comments:
Post a Comment